{"name":"Corcept Therapeutics","slug":"corcept-therapeutics","ticker":"","exchange":"","domain":"","description":"Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":761407000,"revenueGrowth":12.8,"grossMargin":0,"rdSpend":254908000,"netIncome":99652000,"cash":836651000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"CORT125281, 120mg, fasted","genericName":"CORT125281, 120mg, fasted","slug":"cort125281-120mg-fasted","indication":"Other","status":"phase_1"},{"name":"CORT118335 Oral","genericName":"CORT118335 Oral","slug":"cort118335-oral","indication":"Other","status":"phase_1"},{"name":"Miricorilant 100 mg","genericName":"Miricorilant 100 mg","slug":"miricorilant-100-mg","indication":"Other","status":"phase_1"},{"name":"Miricorlilant","genericName":"Miricorlilant","slug":"miricorlilant","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"CORT125281, 120mg, fasted","genericName":"CORT125281, 120mg, fasted","slug":"cort125281-120mg-fasted","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CORT118335 Oral","genericName":"CORT118335 Oral","slug":"cort118335-oral","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Miricorilant 100 mg","genericName":"Miricorilant 100 mg","slug":"miricorilant-100-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Miricorlilant","genericName":"Miricorlilant","slug":"miricorlilant","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVmxnYTA3ZTNJYjVLTjE2WGxlbm5RamRaeXVLX0NqaDVhRjU3Rk1qOFo1WWV4QVpFVVVEejJ0RlRJeDJiUFo0ZHBIZEktaG1aZ19sQU5CRnZacTlzcWliMjlSTnpMM0liUTROOEEtX2p5clFlb09ZLTh0Q0lTaGoyMUlwMlI1OFloQnhLejFoaUNpRUc4TWdNLWluUTZ3MmVZVlpHTDlLa2dNZw?oc=5","date":"2026-04-04","type":"pipeline","source":"National Today","summary":"Corcept Therapeutics Faces Class Action Lawsuit - National Today","headline":"Corcept Therapeutics Faces Class Action Lawsuit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9vOEJXMFBTS3c4aG1MdWJZc3htcmk1QnZZYUhXUE9ENnhMV3RiNEItWDlGUEQyVmphdU5PcWxOLXZramlla1BxQ1dKOS13ZUZqNWNXa2xEVkhiTUUwVHdR?oc=5","date":"2026-04-02","type":"pipeline","source":"ChartMill","summary":"CORT Stock Price, Quote & Chart | CORCEPT THERAPEUTICS INC (NASDAQ:CORT) - ChartMill","headline":"CORT Stock Price, Quote & Chart | CORCEPT THERAPEUTICS INC (NASDAQ:CORT)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-27","type":"pipeline","source":"simplywall.st","summary":"Is Corcept Therapeutics (CORT) Pricing Reflect Its Recent Share Rebound And DCF Upside Potential - simplywall.st","headline":"Is Corcept Therapeutics (CORT) Pricing Reflect Its Recent Share Rebound And DCF Upside Potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNWHQ3SmI3V3J1T2U2VVU5T1l1VkZPQl94SDU3Qm5aZGJvRS1GN3ZIQmNBTXJLWk1LR0FsWU9Zb0RyNmUxN2FTWWNEUDFTNkdMemtXZl9GWXJhT0hraGxpTjU2NFhYRllfUFlubHpHRVVYMUFMMF9HQWRoLVVFYndLR21kaU5rcGJI?oc=5","date":"2026-03-26","type":"regulatory","source":"pharmaphorum","summary":"Corcept gets FDA OK for first-in-class ovarian cancer drug - pharmaphorum","headline":"Corcept gets FDA OK for first-in-class ovarian cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxPU1gtYnBBNXJ3YW5iVXFwOHhDRUpablVjcmtsOEZhZVZSSF9nUFI2dnJtRWp6RGM0UjF2NUg4MkIyWFR4RlBkMmlsc0JOdUwxZE43RlNWZmxCbmoxUnlCWUcwOGVVYXFKQTZBYlpNTGo5bXdxdjRhNTRSYmpsMmYyZGVpdlQwLVJ6NThvWHZXa3NlUzB2aGM2YkdsYmRhUnhabVB5OHJLd3FfWW9ma1VGS0xoUUlGenB0UUR6ZkplVHJVVVdTTzJuaXRZOEQtMG9OdGNYM1c1aGlLZEU?oc=5","date":"2026-03-25","type":"regulatory","source":"Reuters","summary":"Corcept Therapeutics shares surge as lead drug gets FDA nod for ovarian cancer - Reuters","headline":"Corcept Therapeutics shares surge as lead drug gets FDA nod for ovarian cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPRERrZ1hBWlFaV0ZNQkxhakJGaWs3Si1PRHFxNFZIUVlHV1V5MXV0LUZQT1ZiZkxmb1BIU1hGU3h3Smx0aWpIa3ZZS3JDRTJaNkNHWHJXQy1tMzByWDNwRXBsTWtDcEE4N21OY0N1dDhiX0dWRVI3VC1XRVJZRkJWdkRGS2FxVzlrMDFmRUhCR1FTS2tYTEQzby1ON2VaVE5LaWIxLUJ5dkRFd3JBVlhJeExmWQ?oc=5","date":"2026-03-25","type":"regulatory","source":"Fierce Pharma","summary":"Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer - Fierce Pharma","headline":"Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer","sentiment":"positive"},{"date":"2026-03-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOTDh0ZlIyN0NmV2VZRV9hblMtMTVOZzVWajZySGQ0WVNXVURmdU1kR0FNNloyZ01QcnYyN0hoc21UcHY2QjBNUlpqald0dnZEV3dXRGk2bmxTWU9JZFZtajAtWUpwUXlLUjgzRFlzcU9vQmMtOHNqUG9sLVhxVzU4ZW45Rk1KZ2dVcGdmdlIzdWRtSF9sYzFsaFBlRjhSQnJGZkpHOHc3dUQ2TnBpamc?oc=5","date":"2026-03-23","type":"earnings","source":"Yahoo Finance","summary":"Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks - Yahoo Finance","headline":"Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNS2pBVGYzQUhKaWdBYWRVaFJCZm03UHN6YjNiWUwzV0JHTUxKSThpdnVxNlJYd0VVOHp1TzkzMkFMX0pPaE4ySFdNdzM3OEZINmtaOUR1RndlaTM5RGc0NllWTGNFcWNSMldlbUIwMzRlMjBwMF9fUHdEbURybVRiR290WURBTm9IbXA5WW82VU9sSXBxRXQ1alkzT1dWRzZpeGZ1aUlTLXlkNlYtcEdsQU1ISDdOZlVIRF9F?oc=5","date":"2026-02-20","type":"regulatory","source":"Buchanan Ingersoll & Rooney","summary":"Corcept Therapeutics v. Teva Pharmaceuticals: Going Outside the Label To Show No Direct Infringement - Buchanan Ingersoll & Rooney","headline":"Corcept Therapeutics v. Teva Pharmaceuticals: Going Outside the Label To Show No Direct Infringement - Buchanan Ingersol","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQOE1wZlRRVVEzSWZBcFprVTFEc1lLUFlyeTd1azRhNnlWdTlsQUZqT2M4RlRqOWRDcUNCQ2Q2T25sNVBBQk1WSmh4c0RFLVJvNVh3SDlzd2xLa1AwRmFQbFRqamhUZ0p3VTFTYmtYNUFjRVlVcnRGWW50TWR3NFRReGRjcDBCbXJMZTRmbENwUmYyZFY4MUJzY3NXMFVWYjhuaDB1a09mY21xX2VnMnI2RFUzYjVRTzBiM3c1YnZVc3JGZw?oc=5","date":"2026-02-19","type":"patent","source":"Business Wire","summary":"Corcept Provides Update on Patent Dispute with Teva Pharmaceuticals - Business Wire","headline":"Corcept Provides Update on Patent Dispute with Teva Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNTlFzcncyUnhSRVlRQ0hRQkFxcU9zWHBRNXc4TUQ2UmFwRGJHZXR3UnhBNDluUFppTG9xMDdTb19oZzBZSm1RZHZQaEcxalpjV3FMd1hiWmMtc21mYlpGYTgyOVQzS2htcGlxcGtQTS1Pem5GLXhnQkx6Ull4REFzTnh4ajM1bHgtOHk2d3ZWTHdNLTdUSUhManlXcEw5WlFSLUVfbkoyQVMtdlpPaFZodFhmSWktT2htSTRMN2p3ODUydw?oc=5","date":"2026-01-26","type":"pipeline","source":"PharmaTimes","summary":"Corcept Therapeutics’ relacorilant plus nab-paclitaxel shows positive results in ovarian cancer - PharmaTimes","headline":"Corcept Therapeutics’ relacorilant plus nab-paclitaxel shows positive results in ovarian cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNSnFqcjFFYmRSdDJTZWZObDdrc2tLaElfeUtzbU5nUkd2RUJPVHZrZ2g5azRhNkNRbGhUdmRucnVkOHRRZC0tNXlaWlNEUkRFRE1fQVpaaF9YM0xXSS1KcC1hRXBpY0dfRDJKUkJlRGRkRTZIcnpTZ1JybHNkazdlRGRONTJ0eS1qRFNsX0x5T3N4WF9EWlE5YUUzSl8?oc=5","date":"2026-01-22","type":"regulatory","source":"Fierce Biotech","summary":"Corcept racks up phase 3 cancer win to bounce back from FDA Cushing's rejection - Fierce Biotech","headline":"Corcept racks up phase 3 cancer win to bounce back from FDA Cushing's rejection","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPY3hqdUlqdHVpUk1qYno1NzJVNVVOWVRGS2FzVEU2NmJzaUpYRzBVZ0YwNGl1NUs0UWRsWkxXWXplc1lqUHdNeU1qdDVtYzRWaFNLQTZ0SjAzLWFYT01BUmdSc1o2V0M0QXhKbWY0WkdnSkZGZXdLdnJtd1JLejJ6dmFZNHhpdWNyMm1tUGlyOUU?oc=5","date":"2025-12-31","type":"pipeline","source":"Barron's","summary":"Intel to Help SpaceX, Tesla Make Chips. Its Stock Is Up. - Barron's","headline":"Intel to Help SpaceX, Tesla Make Chips. Its Stock Is Up. - Barron's","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_1":3,"phase_2":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":761407000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":761407000,"period":"2025-12-31"},{"value":675040000,"period":"2024-12-31"},{"value":675040000,"period":"2024-12-31"},{"value":482375000,"period":"2023-12-31"},{"value":482375000,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":254908000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":99652000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":836651000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}